One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...
InvestorsHub on MSN
Emergent BioSolutions gets FDA clearance for new OTC NARCAN nasal spray portable case
Emergent BioSolutions (NYSE:EBS) said the U.S. Food and Drug Administration has approved a supplemental New Drug Application ...
Letitia James accused Robert Kramer of selling his shares in Emergent before disclosing contamination issues in its ...
New York AG Tish James sued former Emergent BioSolutions CEO over alleged insider trading around the COVID vaccine.
Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with ...
Shares of Emergent BioSolutions fell after it reached a settlement with New York Attorney General Letitia James over accusations of insider trading by the company's former chief executive. Shares fell ...
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...
Since the U.S. prescription launch of NARCAN® Nasal Spray in 2016, the medicine has been trusted as a safe, effective way to reverse opioid ...
Emergent BioSolutions Inc. (NYSE:EBS) is one of the Best Performing Affordable Stocks Under $40. On January 8, Emergent ...
New York Attorney General sued the former CEO of Emergent BioSolutions, Robert G. Kramer, for insider trading.
Former Emergent BioSolutions Inc. CEO Robert Kramer engaged in illegal insider trading during the Covid-19 pandemic, ...
Narcan Nasal Spray is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback